NAKAMURA HIDEJI | Division of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Hyogo College of

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K_2
New chemotherapy for patients with advanced hepatocellular carcinoma : Pilot study of β-interferon and doxorubicin one-shot intra-arterial chemotherapy
Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene
Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor
Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor
Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines
Hemochromatosis with Mutation of the Ferroportin 1 (IREG1) Gene
Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells
Hepatoma-derived growth factor is induced in liver regeneration

スポンサーリンク